Renal endothelial dysfunction and hypertension

被引:13
|
作者
Higashi, Y [1 ]
Chayama, K [1 ]
机构
[1] Hiroshima Univ, Sch Med, Dept Internal Med 1, Cardiovasc Div,Minami Ku, Hiroshima 7348551, Japan
关键词
nitric oxide; L-arginine; renal endothelial function; hypertension;
D O I
10.1016/S1056-8727(01)00202-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with essential hypertension have an impaired endothelium-dependent vascular relaxation in the renal arteries. The possible mechanisms by which essential hypertension is associated with alterations in endothelial function are decreased endothelial nitric oxide (NO) synthase activity, decreased availability or deficiency of L-arginine, increased endogenous NO synthase inhibitor, inactivation of NO by superoxide anions, and increased vasoconstrictors. However, the precise mechanism is not known. In addition, we are now confronted with a difficult question. And the question is whether endothelial dysfunction is a cause or consequence of hypertension. We hypothesize that the initial endothelial dysfunction raises blood pressure, and the development of hypertension impairs much more endothelial function, resulting in constituting the vicious cycle between endothelial dysfunction and hypertension. However, at the moment, it is impossible to answer this question with any certainty. Impairment of endothelial function has been shown to play a critical role in the development and maintenance of hypertension. It is clinically important to select an appropriate intervention that is effective in improving endothelial dysfunction in patients with essential hypertension. Several investigators including us have demonstrated that certain interventions improve endothelial dysfunction of forearm and renal circulation in patients with essential hypertension: angiotensin-converting enzyme inhibitors: lifestyle modification: exercise, body weight reduction, and sodium reduction: estrogen replacement in postmenopausal women: and novel properties: vitamin c and tetrahydrobiopterine. In patients with essential hypertension, endothelial function is impaired in several arteries. However, endothelial dysfunction in essential hypertension is reversible. We can restore endothelial function in essential hypertensive patients. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:103 / 107
页数:5
相关论文
共 50 条
  • [31] Endothelial dysfunction in essential hypertension
    Panza, JA
    CLINICAL CARDIOLOGY, 1997, 20 (11) : 26 - 33
  • [32] Arterial hypertension, endothelial microparticles, and endothelial dysfunction
    Sansone, R.
    Baaken, M.
    Schuler, D.
    Horn, P.
    Cortese-Krott, M.
    Westenfeld, R.
    Kelm, M.
    Heiss, C.
    EUROPEAN HEART JOURNAL, 2015, 36 : 203 - 203
  • [33] Endothelial dysfunction as one mechanism to cause cardio-renal connection in hypertension
    Yamamoto, K.
    Takeda, Y.
    Yamashita, S.
    Sugiura, T.
    Wakamatsu, Y.
    Fukuda, M.
    Ohte, N.
    Dohi, Y.
    Kimura, G.
    JOURNAL OF HYPERTENSION, 2008, 26 : S173 - S173
  • [34] Renal dysfunction impairs circadian variation of endothelial function in patients with essential hypertension
    Yamamoto, Koji
    Takeda, Yutaka
    Yamashita, Sumiyo
    Sugiura, Tomonori
    Wakamatsu, Yoshimasa
    Fukuda, Michio
    Ohte, Nobuyuki
    Dohi, Yasuaki
    Kimura, Genjiro
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2010, 4 (06) : 265 - 271
  • [35] Endothelial dysfunction in renal transplantation
    Crespo, M
    Campistol, JM
    NEFROLOGIA, 2003, 23 : 52 - 58
  • [36] NILVADIPINE IN HYPERTENSION WITH RENAL DYSFUNCTION
    BERGER, HH
    ALBERT, FW
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S73 - S79
  • [37] Simvastatin and Tempol Protect Against Endothelial Dysfunction and Renal Injury in a Model of Obesity and Hypertension
    Knight, Sarah F.
    Yuan, Jianghe
    Roy, Siddhartha
    Imig, John D.
    FASEB JOURNAL, 2008, 22
  • [38] Simultaneous renal hypertension and type 2 diabetes exacerbate vascular endothelial dysfunction in rats
    Khalili, Azadeh
    Nekooeian, Ali Akbar
    Khosravi, Mohammad Bagher
    Fakher, Shima
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2012, 93 (03) : 210 - 217
  • [39] Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension
    Knight, Sarah F.
    Yuan, Jianghe
    Roy, Siddhartha
    Imig, John D.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2010, 298 (01) : F86 - F94
  • [40] Oxidative stress and endothelial dysfunction in hypertension
    Schulz, Eberhard
    Gori, Tommaso
    Muenzel, Thomas
    HYPERTENSION RESEARCH, 2011, 34 (06) : 665 - 673